Skip to the page

Data / Form D filings / Georgiamune, Inc.

Georgiamune, Inc.: Form D filing

Georgiamune, Inc., a biotechnology company in Gaithersburg, MD, filed a Form D with the SEC in 2026. The latest, on August 17, 2026, reports $92.7 million sold of a $131.9 million offering to 26 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
940 Clopper Road Suite 942, Gaithersburg, MD, 20878
Phone
(706) 831-4549
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2148230

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 17, 2026New notice$131,852,011$92,692,709$39,159,30226Jul 16, 2026sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Samir N. KhleifExecutive Officer, Director
Sean ParkerDirector
Elena VibochDirector
Nancy OndovikDirector
Paul BrownDirector
Fredrick SchaufeldDirector
Amy AbernethyDirector

Other biotechnology companies in Maryland that filed recently

Every Form D from the week of Aug 17, 2026 · All recent filings in Maryland · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Georgiamune, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.